11 | SXL up +1.93% percent Today $SXL Stock High is at | Lucky Jimmy | 12/31/2015 11:25:10 AM |
10 | SXL up +5.17% percent Today $SXL Stock High is at | Lucky Jimmy | 12/16/2015 6:11:51 PM |
9 | SXL 42.59 Sunoco Logistics Partners LP $SXL stock | clayton | 04/22/2015 5:58:19 PM |
8 | SXL Stock year to date has changed +8.90% | Jake13 | 02/24/2015 8:52:29 AM |
7 | SXL 45.50 Sunoco Logistics Partners LP Stock | chartguy89 | 02/24/2015 8:04:32 AM |
6 | SXL 50.15 Sunoco Logistics Partners LP $SXL Hit a | DennyT | 11/24/2014 1:56:27 PM |
5 | SXL Year to date has changed +35.06% percent. | Jake13 | 11/21/2014 5:46:53 AM |
4 | SXL 50.97 Sunoco Logistics Partners LP Stock | chartguy89 | 11/21/2014 5:15:08 AM |
3 | SXL up +0.14% percent Today $SXL High is at 50.55 | Lucky Jimmy | 11/19/2014 2:43:13 PM |
2 | Latest Sunoco Logistics Partners LP (SXL) | Stock_Tracker | 03/14/2014 9:03:11 AM |
1 | SXL Stock Charts Last: -0.66 Tuesday, March 4, | chartguy89 | 03/04/2014 3:42:52 AM |
Recent Articles
- Understanding Key Economic Strategies from China's Leadership Meeting
- Financière de Tubize Announces Annual Dividend Distribution
- Celebrating Cinema at the 20th China Film Huabiao Awards
- Movado Group Faces SEC Scrutiny, Rosen Law Firm Steps In
- Experience the Thrill of Japan Open Poker Tour 2025
- A.I.S. Resources Completes Successful Private Placement Initiative
- Ready Capital Shareholder Legal Updates: Know Your Rights
- Investors Urged to Act: Lawsuits Filed Against e.l.f. Beauty
- Understanding Your Rights as a Bancorp Investor in Legal Matters
- Important Update for Viatris Investors: Legal Action Insights
- AppLovin Investors Reminded of Important Class Action Deadline
- Investors Have a Deadline to Join NET Power Class Action
- Fluence Energy Class Action Update: Important Deadline Approaches
- AppLovin Corporation Faces Shareholder Class Action Opportunities
- Formosa Pharmaceuticals Partners With Saval For New Eye Treatment
- Antengene Showcases Innovative Therapeutics at AACR Event
- 51Talk Online Education Group Releases Key Annual Report for 2024
- Skye Bioscience Unveils Stock Option Grant for New Employee
- Innovent Celebrates NMPA Approval of Limertinib for Lung Cancer Treatment
- Willow Biosciences Reveals Results from Recent Shareholder Meeting
- Investigation into Bitfarms Ltd: What Investors Should Know
- Investigation into HealthEquity, Inc. Sparks Investor Interest
- Creative Science Expands Horizons with Astaria Global Acquisition
- Investors Encouraged to Join Canopy Growth Class Action Suit
- Rosen Law Firm Initiates Investigation for Bitfarms Investors
- Agnico Eagle's 2025 Shareholder Meeting: Directors Elected
- Orbia's Exciting Offer: Tender for Senior Notes Unveiled
- Concord Medical Submits Annual Report for Fiscal Year 2024
- BankFirst Capital Corporation Posts Strong Q1 Performance
- Espire Dental Unifies Workforce at Engaging Conference Event
- Aliya Health Group Welcomes New Leaders to Enhance Care
- 17 Education & Technology Group Inc. Releases Annual Financial Report
- Kellanova Board Approves New $0.57 Dividend for Shareholders
- Exploring Christian Zionism: New Podcast Series Launches
- Graze Robotics and Invited Launch Pioneering Mowing Initiative
- Medtronic's OmniaSecure Lead Revolutionizes Cardiac Care Innovations
- Celebrate Planning with Plum Paper's Customer Appreciation Sale
- Innovative Grant Initiative to Foster Community Health Equity
- Investigating the HarborOne Bancorp and Eastern Bankshares Deal
- Celularity Faces Delisting Notice From Nasdaq Over Fees
- Paul Mueller Company Q1 Earnings Show Significant Growth
- Trillion Energy Takes Major Steps to Restructure Debt Efficiently
- Credicorp Ltd. Files Annual Report Showcasing Growth Insights
- Wheels Up's Commitment to Strategic Growth Amid NYSE Notice
- Fairfax Financial Holdings to Host Conference Call for Q1 Results
- AGF Investments Reveals New Final Distribution for ETF Holders
- Lug's Commitment to Sensory Accessibility with KultureCity Partnership
- Cadence Bank and Industry Bancshares Join Forces in Merger
- Zepp Health Corporation Announces Filing of 2024 Annual Report
- Innovative Neuro-Oncology Solutions with Dr. Neil A. Martin